CaPP3 Study opens to recruitment

posted on Monday, 13th October 2014

Not tagged.

[#pageName]

The CaPP3 study opened to recruitment at the Institute of Genetic Medicine, Newcastle on Wednesday 1st October 2014. Professor Sir John Burn consented the first recruit.

The first batch of packed aspirin has been delivered to the pharmacy in Newcastle ready for dispensing.

The study will be recruiting through all the UK Regional Genetics Centres. Over the next few months these centres too will be opening to recruitment, once they have completed their local regulatory processes.

So after several long years of working our way through UK regulatory processes the CaPP3 study is finally open to recruitment.

Nick James was the first to be recruited to the trial in Newcastle.  Read his story at the link below:

Gosforth dad joins clinical trial that could cut risk of Lynch syndrome sufferers getting cancer

ChronicleLive, 7 October 2016

 

Share this!

Latest News

  • 08

    Feb

    2018

    CaPP3 Australia

    posted on Thursday, 8th February 2018
    CaPP3 Australia

    From left to right: Finlay Macrae, Zafirah Khan (CaPP3 Research Coordinator at the Royal Melbourne Hospital) and John Burn

    Not tagged.

    Comments (0)

  • 08

    Feb

    2018

    Welcome to new team members in Leicester

    posted on Thursday, 8th February 2018
    Welcome to new team members in Leicester

    Leicester CaPP3 Team: from left to right - Sarah Porter, Liz Andrzejewski, Julian Barwell, Hannah Holdsworth

    Not tagged.

    Comments (0)

Downloads